Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
We are changing the way food is made by using technology that increases efficiency and improves lives.
Complion offers an eRegulatory solution for clinical research sites.
SafeWire provides software to title companies to combat wire fraud in real estate transactions.
Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy types.
Ecolibrium Solar is committed to revolutionizing the solar power market. We design simple, cost effective and ecologically sound products
Innovate IP is a modern, web-based platform used by research institutions to manage their Intellectual Property Assets.
Lyst Therapeutics determines the effect of LYST antibody on inhibiting the formation of tissue engineered vascular graft stenosis.
Unific is helping retailers grow by attracting, converting and retaining customers.
Milo Biotechnology develops technologies and programs to improve the lives of patients with neuromuscular diseases.
Ardina is a simple & affordable healthcare membership program that gives 24/7 access to physicians, telemedicine, and wellness.
EduSourced is a cloud-based software tool for educators to manage and track industry-sponsored learning projects.
Capture Education is the leading automation engine for class scheduling and recommendation
One Exchange Street, Inc. operates as an exchange for online trading in bankruptcy claims.
SironRX is developing novel therapies that promote dermal wound repair and reduce scarring.
Rev1 Ventures has invested in 86 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Rev1 Ventures's top investment sectors include Health Care, Software, Therapeutics, Enterprise Software, Biotechnology. The firm invests across 34 different industry categories.
Among tracked funding rounds, Myonexus Therapeutics received $60.0M in a Corporate Round round. Rev1 Ventures's total known invested capital is $665.8M.
Rev1 Ventures's average investment size is $11.7M across its portfolio of 86 companies.